COVID-19 Alert

GI Dynamics has taken all necessary COVID-19 precautions to ensure patient safety, which remains top priority. Patient screening for the STEP-1 pivotal trial of EndoBarrier has reopened at select sites and enrollment will be conducted according to site requirements and CDC/FDA guidelines.

For more information please email info@gidynamics.com.

The Need by the Numbers

The Treatment Gap